Lycopene and apo-12′-lycopenal reduce cell proliferation and alter cell cycle progression in human prostate cancer cells

Nutrition and Cancer

Volumn 63, Issue 2, 2011, Pages 256-263

  Ford, Nikki A ^a   Elsen, Amy C ^a   Zuniga, Krystle ^a   Lindshield, Brian L ^a   Erdman Jr , John W ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APO 12' LYCOPENAL; APO 8' LYCOPENAL; CONNEXIN 43; LYCOPENE; PLACEBO; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CELL CYCLE PROGRESSION; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; FIBROBLAST; MALE; MOUSE; NONHUMAN; PROSTATE CANCER; RAT;

ALDEHYDES; ANALYSIS OF VARIANCE; ANIMALS; ANTICARCINOGENIC AGENTS; APOPTOSIS; CAROTENOIDS; CELL CYCLE; CELL PROLIFERATION; CELLS, CULTURED; DISEASE PROGRESSION; FIBROBLASTS; HUMANS; LYCOPERSICON ESCULENTUM; MALE; MICE; PROSTATIC NEOPLASMS; RATS; RETINOIDS; TERPENES;

LYCOPERSICON ESCULENTUM; RATTUS;

EID: 79951864386     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1080/01635581.2011.523494     Document Type: Article

References (46)

1. Horner MJ, Ries LAG, Krapcho M, Neyman N, Aminou R, et al.: SEER Cancer Statistics Review, 1975-2006, National Cancer Institute, Bethesda, MD, http://seer.cancer.gov/csr/1975 2006/, based on November 2008 SEER data submission, posted to the SEER Web site, 2009.
2. Giovannucci E, Ascherio A, Rimm EB, Stampfer MJ, Colditz GA, et al.: Intake of carotenoids and retinol in relation to risk of prostate cancer. J Natl Cancer Inst 87, 1767-76, 1995.
3. Etminan M, Takkouche B, and Caamano-Isorna F: The role of tomato products and lycopene in the prevention of prostate cancer: a meta-analysis of observational studies. Cancer Epidemiol Biomarkers Prev 13, 340-345, 2004. (Pubitemid 38737456)
4. Van Patten CL, de Boer JG, and Tomlinson Guns ES: Diet and dietary supplement intervention trials for the prevention of prostate cancer recurrence: a review of the randomized controlled trial evidence. J Urol 180, 2314-2321; discussion 2721-2722, 2008.
5. Wyss A, Wirtz GM, Woggon WD, Brugger R, Wyss M, et al.: Expression pattern and localization of beta,beta-carotene 15,15′-dioxygenase in different tissues. Biochem J 354, 521-529, 2001. (Pubitemid 32269715)
6. Hu KQ, Liu C, Ernst H, Krinsky NI, Russell RM, et al.: The biochemical characterization of ferret carotene-9′,10′-monooxygenase catalyzing cleavage of carotenoids in vitro and in vivo. J Biol Chem 281, 19327-19338, 2006. (Pubitemid 44035438)
7. Gajic M, Zaripheh S, Sun F, and Erdman JW: Apo-8′-lycopenal and apo-12′-lycopenal are metabolic products of lycopene in rat liver. J Nutr 136, 1552-1557, 2006. (Pubitemid 43765361)
8. Kopec RE, Riedl KM, Harrison EH, Curley RW, Jr., Hruszkewycz DP, et al.: Identification and quantification of apo-lycopenals in fruits, vegetables, and human plasma. J Agric Food Chem 58, 3290-3296, 2010.
9. Wu K, Erdman JW, Schwartz SJ, Platz EA, Leitzmann M, et al.: Plasma and dietary carotenoids, and the risk of prostate cancer: a nested case-control study. Cancer Epidemiol Biomarkers Prev 13, 260-269, 2004. (Pubitemid 38222558)
10. Canene-Adams K, Lindshield BL, Wang S, Jeffery EH, Clinton SK, et al.: Combinations of tomato and broccoli enhance antitumor activity in Dunning r3327-h prostate adenocarcinomas. Cancer Res 67, 836-843, 2007. (Pubitemid 46192225)
11. Peternac D, Klima I, Cecchini MG, Schwaninger R, Studer UE, et al.: Agents used for chemoprevention of prostate cancer may influence PSA secretion independently of cell growth in the LNCaP model of human prostate cancer progression. Prostate 68,1307-1318, 2008.
12. Gunasekera RS, Sewgobind K, Desai S, Dunn L, Black HS, et al.: Lycopene and lutein inhibit proliferation in rat prostate carcinoma cells. Nutr Cancer 58, 171-177, 2007. (Pubitemid 47333827)
13. Ivanov NI, Cowell SP, Brown P, Rennie PS, Guns ES, et al. Lycopene differentially induces quiescence and apoptosis in androgen-responsive and -independent prostate cancer cell lines. Clin Nutr 26, 252-263, 2007. (Pubitemid 46477835)
14. Kanagaraj P, Vijayababu MR, Ravisankar B, Anbalagan J, Aruldhas MM, et al.: Effect of lycopene on insulin-like growth factor-I, IGF binding protein-3 and IGF type-I receptor in prostate cancer cells. J Cancer Res Clin Oncol 133, 351-359, 2007. (Pubitemid 46716699)
15. Hwang ES and Bowen PE: Effects of lycopene and tomato paste extracts on DNA and lipid oxidation in LNCaP human prostate cancer cells. Biofactors 23, 97-105, 2005.
16. Tang L, Jin T, Zeng X, and Wang JS: Lycopene inhibits the growth of human androgen-independent prostate cancer cells in vitro and in BALB/c nude mice. J Nutr 135, 287-290, 2005. (Pubitemid 40194493)
17. Forbes K, Gillette K, and Sehgal I: Lycopene increases urokinase receptor and fails to inhibit growth or connexin expression in a metastatically passaged prostate cancer cell line: A brief communication. Exp Biol Med (Maywood) 228, 967-971, 2003. (Pubitemid 37163250)
18. Kim L, Rao AV, and Rao LG: Effect of lycopene on prostate LNCaP cancer cells in culture. J Med Food 5, 181-187, 2002. (Pubitemid 36331630)
19. Kotake-Nara E, Kushiro M, Zhang H, Sugawara T, Miyashita K, et al.: Carotenoids affect proliferation of human prostate cancer cells. J Nutr 131, 3303-3306, 2001. (Pubitemid 33136153)
20. Hantz HL, Young LF, and Martin KR: Physiologically attainable concentrations of lycopene inducemitochondrial apoptosis in LNCaP human prostate cancer cells. Exp Biol Med (Maywood) 230, 171-179, 2005. (Pubitemid 40293690)
21. Burgess LC, Rice E, Fischer T, Seekins JR, Burgess TP, et al.: Lycopene has limited effect on cell proliferation in only two of seven human cell lines (both cancerous and noncancerous) in an in vitro system with doses across the physiological range. Toxicol in Vitro 22, 1297-1300, 2008.
22. Erdman JW, Jr., Ford NA, and Lindshield BL: Are the health attributes of lycopene related to its antioxidant function? Arch Biochem Biophys 483, 229-235, 2009.
23. Hwang ES and Bowen PE: Cell cycle arrest and induction of apoptosis by lycopene in LNCaP human prostate cancer cells. J Med Food 7, 284-289, 2004.
24. Markovitch D, Tyrrell RM, Tauler P, Frystyk J, Stokes K, et al.: Lycopene supplementation (passata sauce) reduces apoptosis but does not affect oxidant-responsive heme oxygenase-1 in human lymphocytes. Nutrition 25, 668-675, 2009.
25. Palozza P, Simone R, Catalano A, Boninsegna A, Bohm V, et al.: Lycopene prevents 7-ketocholesterol-induced oxidative stress, cell cycle arrest and apoptosis in human macrophages. J Nutr Biochem 21, 34-46, 2009.
26. Lordan S, O'Neill C, and O'Brien NM: Effects of apigenin, lycopene and astaxanthin on 7 beta-hydroxycholesterol-induced apoptosis and akt phosphorylation in U937 cells. Br J Nutr 100, 287-296, 2008.
27. King TJ and Bertram JS: Connexins as targets for cancer chemoprevention and chemotherapy. Biochim Biophys Acta 1719, 146-160, 2005. (Pubitemid 41785642)
28. Leithe E and Rivedal E. Ubiquitination of gap junction proteins. J Membr Biol 217, 43-51, 2007. (Pubitemid 350160007)
29. Britton G, Liaaen-Jensen S, and Pfander H: Carotenoids, Vol. 4. Natural Functions, Birkhauser Basel, Switzerland, 2008.
30. Bureyko T, Hurdle H, Metcalfe JB, Clandinin MT, and Mazurak VC: Reduced growth and integrin expression of prostate cells cultured with lycopene, vitamin E and fish oil in vitro. Br J Nutr 101, 990-997, 2009.
31. Richards LR, Benghuzzi H, Tucci M, and Hughes J: The synergistic effect of conventional and sustained delivery of antioxidants on LNCaP prostate cancer cell line. Biomed Sci Instrum 39, 402-407, 2003. (Pubitemid 36433460)
32. Pastori M, Pfander H, Boscoboinik D, and Azzi A: Lycopene in association with alpha-tocopherol inhibits at physiological concentrations proliferation of prostate carcinoma cells. Biochem Biophys Res Commun 250, 582-585, 1998. (Pubitemid 28484769)
33. Kim SJ, Nara E, Kobayashi H, Terao J, and Nagao A: Formation of cleavage products by autoxidation of lycopene. Lipids 36, 191-199, 2001. (Pubitemid 32216924)
34. Ben-Dor A, Steiner M, Gheber L, Danilenko M, Dubi N, et al.: Carotenoids activate the antioxidant response element transcription system. Mol Cancer Ther 4, 177-186, 2005. (Pubitemid 40268075)
35. Kotake-Nara E, Kim SJ, Kobori M, Miyashita K, and Nagao A: Acycloretinoic acid induces apoptosis in human prostate cancer cells. Anticancer Res 22, 689-695, 2002. (Pubitemid 34475215)
36. Nara E, Hayashi H, Kotake M, Miyashita K, and Nagao A: Acyclic carotenoids and their oxidationmixtures inhibit the growth of HL-60 human promyelocytic leukemia cells. Nutr Cancer 39, 273-283, 2001. (Pubitemid 33694047)
37. Zhang H, Kotake-Nara E, Ono H, and Nagao A: A novel cleavage product formed by autoxidation of lycopene induces apoptosis in HL-60 cells. Free Radic Biol Med 35, 1653-1663, 2003. (Pubitemid 37532916)
38. Lian F, Smith DE, Ernst H, Russell RM, and Wang XD: Apo-10′- lycopenoic acid inhibits lung cancer cell growth in vitro, and suppresses lung tumorigenesis in the A/J mouse model in vivo. Carcinogenesis 28, 1567-1574, 2007. (Pubitemid 47241807)
39. Lian F and Wang XD: Enzymatic metabolites of lycopene induce Nrf2-mediated expression of phase II detoxifying/antioxidant enzymes in human bronchial epithelial cells. Int J Cancer 123, 1262-1268, 2008.
40. Linnewiel K, Ernst H, Caris-Veyrat C, Ben-Dor A, Kampf A, et al.: Structure activity relationship of carotenoid derivatives in activation of the electrophile/antioxidant response element transcription system. Free Radic Biol Med 47, 659-667, 2009.
41. Mein JR, Lian F, and Wang XD: Biological activity of lycopene metabolites: Implications for cancer prevention. Nutr Rev 66, 667-683, 2008.
42. Zhang LX, Cooney RV, and Bertram JS: Carotenoids upregulate connexin43 gene expression independent of their provitamin A or antioxidant properties. Cancer Res 52, 5707-5712, 1992.
43. Rogers M, Berestecky JM, Hossain MZ, Guo HM, Kadle R, et al.: Retinoid-enhanced gap junctional communication is achieved by increased levels of connexin 43 mRNA and protein. Mol Carcinog 3, 335-343, 1990.
44. Aust O, Ale-Agha N, Zhang L, Wollersen H, Sies H, et al.: Lycopene oxidation product enhances gap junctional communication. Food Chem Toxicol 41:1399-1407, 2003. (Pubitemid 37289189)
45. Khachik F, Beecher GR, Smith JC, Jr.: Lutein, lycopene, and their oxidative metabolites in chemoprevention of cancer. J Cell Biochem 22(Suppl), 236-246, 1995.
46. Stahl W, von Laar J, Martin HD, Emmerich T, and Sies H: Stimulation of gap junctional communication: Comparison of acyclo-retinoic acid and lycopene. Arch Biochem Biophys 373, 271-274, 2000. (Pubitemid 30046514)